🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: differin

Found 0 matching trials

Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris

PHASE4

Comparison of the safety and efficacy of Tazarotene Cream 0.1% compared wit...

Status

Terminated

Location

Multiple Locations

Start Date

2007-10

Trial ID

NCT00829049

Treatments Being Tested

Tazarotene Cream 0.1%Adapalene

Experience With Topical Acne Treatment

EARLY_PHASE1

Acne is a chronic condition that typically requires the use of multiple med...

Status

Active Not Recruiting

Location

Wake Forest University Health Sciences

Start Date

2024-02-15

Trial ID

NCT05582434

Treatments Being Tested

clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel adapalene 0.3%/BPO 2.5% gel and compounded clindamycin phosphate 1.2% gel Compounded BPO 2.5% gel, adapalene 0.1% gel, and compounded clindamycin phosphate 1.2% gel

Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris

PHASE3

To evaluate the therapeutic equivalence and safety of Adapalene Gel 0.3% (A...

Status

Completed

Location

Unison Center for Clinical Trials

Start Date

2018-09-17

Trial ID

NCT03650361

Treatments Being Tested

Adapalene Gel 0.3%Differin 0.3% Topical Gel Adapalene Gel 0.3% Vehicle Placebo

A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging

PHASE3

The purpose of this study is to: 1. Evaluate the efficacy of Adapalene gel...

Status

Completed

Location

Centro de Dermatologia Dona Libania

Start Date

2013-01

Trial ID

NCT01406080

Treatments Being Tested

Adapalene Tretinoin

Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris

PHASE4

Comparing the efficacy and safety of a gel formulation containing a combina...

Status

Completed

Location

Prof A Langner

Start Date

2004-12

Trial ID

NCT00160394

Treatments Being Tested

Duac® Gel / Differin® Gel

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

PHASE4

This study is to determine the efficacy and safety of 12 week treatment wit...

Status

Completed

Location

Center for Dermatology and Laser Surgery

Start Date

2007-12

Trial ID

NCT00671749

Treatments Being Tested

adapalene gel, 0.3%clindamycin/benzoyl peroxide gel

Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)

PHASE4

The aim of the study is to investigate the effectivity of visible light in ...

Status

Unknown

Location

Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden

Start Date

2006-09

Trial ID

NCT00237978

Treatments Being Tested

Adapalen VIS and wIRA

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

PHASE1

The purpose of this study is to compare the tolerability of Differin® (adap...

Status

Completed

Location

Thomas J. Stephens & Associates, Inc.

Start Date

2010-01

Trial ID

NCT01046565

Treatments Being Tested

adapalene cream 0.1%adapalene lotion 0.1%

Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%

PHASE4

The primary objective of this study is to investigate potential differences...

Status

Completed

Location

Wake Forest School of Medicine

Start Date

2006-06

Trial ID

NCT00437151

Treatments Being Tested

More frequent than normal office visits Electronic reminders (voice, e-mail, text messages)Parenteral involvement / intervention reminders No intervention or reminders

Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris

PHASE4

The primary objective of this study is to investigate potential differences...

Status

Completed

Location

Wake Forest University Health Sciences Dermatology

Start Date

2006-06

Trial ID

NCT00696449

Treatments Being Tested

Adapalene frequent visits electronic reminder Parent reminder Standard of care

Previous Next